ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Viveon Health Acquisition Corp

Viveon Health Acquisition Corp (VHAQ)

10.81
0.00
(0.00%)
At close: January 16 4:00PM
10.81
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
10.81
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
10.81
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

VHAQ Latest News

Tech Centric Healthcare Services Company Continues To Move Forward With Its Business Combination and Exchange Listing

San Antonio, Texas, July 22, 2024 (GLOBE NEWSWIRE) -- Clearday (CLRD:OTC EXMKT ) (“Clearday” or the “Company”) is pleased to inform market participants, partners and stakeholders of the...

Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success - Updated

San Antonio, TX, May 03, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD), a healthcare services company focused on bringing innovative products and services to the senior care industry, would...

Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success

San Antonio, TX, May 02, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD), a healthcare services company focused on bringing innovative products and services to the senior care industry, would...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

VHAQ - Frequently Asked Questions (FAQ)

What is the current Viveon Health Acquisition share price?
The current share price of Viveon Health Acquisition is $ 10.81
What is the 1 year trading range for Viveon Health Acquisition share price?
Viveon Health Acquisition has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TAFLAB Tax Aware Long Municipal ETF
$ 31.25
(25.17%)
3.01k
ITPIT Tech Packaging Inc
$ 0.44
(7.58%)
19.19k
NBYNovaBay Pharmaceuticals Inc New
$ 0.7399
(5.75%)
1.46k
BURUNuburu Inc
$ 0.46
(5.43%)
12.37k
UAVSAgEagle Aerial Systems Inc
$ 3.01
(4.88%)
36.79k
SCPXScorpius Holdings Inc
$ 0.3381
(-10.32%)
99.31k
ROLRHigh Roller Technologies Inc
$ 5.7747
(-6.56%)
364
AEONAEON Biopharma Inc
$ 0.1601
(-6.32%)
3.31M
DDCDDC Enterprise Limited
$ 0.1711
(-5.47%)
89.54k
PWPower REIT
$ 1.14
(-5.00%)
190
SPYSPDR S&P 500
$ 590.99
(-0.11%)
11.82M
TDTTFlexShares iBoxx 3 Year Target Duration TIPS Index Fund
$ 23.77
(0.00%)
3.33M
AEONAEON Biopharma Inc
$ 0.1601
(-6.32%)
3.31M
FOXOFOXO Technologies Inc
$ 0.3111
(-1.24%)
2.74M
PULSPgim Ultra Short Bond ETF
$ 49.65
(0.00%)
2.11M

VHAQ Discussion

View Posts
Renee Renee 11 months ago
VHAQ delisted from the AMEX to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
👍️0
NYCJR NYCJR 2 years ago
you're replying to a post from 2 years ago, this was a spec play back then, its obviously been a disaster since, is that how you do dd? dig up 2 year old posts smh.
👍️0
John_Vallay John_Vallay 2 years ago
Where is the value in this deal.

CLRD is a bad company with losses and based on their balance sheet and some recent announcements it looks as if they are giving up on some of their properties and senior living residences. If I am reading everything correctly CLRD revenues will be going down.

If they are banking on AI or robotics, it must be noted that Clearday doesn't own any AI or robotics. They are merely a reseller, but I don't know if they ever resold anything as of yet.

Unless I am wrong VHAQ is a short if I ever seen one.

Am I missing something here?
can someone give me a perspective that I may be overlooking?
Can someone explain to me the fundamentals of a deal that combines VHAQ and CLRD?
I do ask for fundamentals not opinions, dreams and hopes.
👍️0
ANTI-BAGHOLDER ANTI-BAGHOLDER 2 years ago
Yeah, but the merger with CLRD should bring value.
👍️0
NYCJR NYCJR 2 years ago
im so red on those warrants, still holding em, hopefully the go back above my avg of 30 cents smh!
👍️0
ANTI-BAGHOLDER ANTI-BAGHOLDER 2 years ago
$CLRD news out valued at $250 million. Merger with $VHAQ

Norcross, Georgia, and San Antonio, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU), a special purpose acquisition company led by principals experienced in healthcare and med-tech innovation, is pleased to announce that it has identified and entered into a letter of intent with a business combination target company, Clearday (OTCQX: CLRD).

https://www.otcmarkets.com/stock/VHAQ/news/story?e&id=2461565
👍️0
NYCJR NYCJR 4 years ago
i keep adding here every day, will pay nicely once they combine!
👍️0
NYCJR NYCJR 4 years ago
this is a tremendous ground floor opportunity here!
👍️0
FreeMustacheRides1 FreeMustacheRides1 4 years ago
2:1 warrants isn’t bad. I will start a position now in High .30s/low .40s.
Love a good warrant play trading under .50.
👍️0
NYCJR NYCJR 4 years ago
Viveon Health Acquisition is a blank check company formed under the laws of the State of Delaware on August 7, 2020.

We were formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination.

Our efforts to identify a prospective target business will not be limited to any particular industry or geographic region, although we intend to focus our search on target healthcare businesses operating in North America.

Jagi Gill, PhD, our Chief Executive Officer, has more than 20 years of healthcare investment and general management experience. From 2017 to 2020, he served as the Vice-President of Business Development and General Manager of AcuVentures, a business unit within Acumed LLC, which is a market leader in the orthopedic sector with particular strength in the upper extremity fracture repair and trauma market segments.

As the General Manager, Dr. Gill led two business units, Rib Fixation and the Soft Tissue Repair, with responsibilities for product development, sales, marketing and profitability.

Under his leadership, the business units grew 2-3x faster than their market segment. In addition to general management responsibilities, Dr. Gill was involved in sourcing, closing and integrating four acquisitions within the orthopedic sector for Acumed.

These transactions ranged from technology acquisitions serving as tuck-in product integrations to stand alone companies with global revenue.
👍️0
NYCJR NYCJR 4 years ago
warrants here are a steal people, deal incoming shortly, bottom is in!
👍️0

Your Recent History

Delayed Upgrade Clock